Connect your AI client via MCP

Endpoint (paste into an MCP client — anonymous, free, no key)

https://mcp.koalcheck.com/mcp

Or copy this and send it to your AI to set it up:

Add the "koalcheck" MCP server to my client and connect. It is a remote Streamable-HTTP server at https://mcp.koalcheck.com/mcp — connect anonymously, no API key or login needed (the free tools work right away). If my client supports a remote/HTTP MCP server directly, just use that URL. If my client config only accepts a local command (e.g. Claude Desktop's mcpServers, which rejects a bare "url"), bridge it with command "npx" and args ["-y","mcp-remote","https://mcp.koalcheck.com/mcp"]. Then tell me to fully restart the client, and list the koalcheck tools you can call. It provides US-equity research tools built on an analyst track-record engine (who has actually been right, priced vs SPY, cross-checked with SEC & FINRA).

Capabilities User guide

← @crypto_biotech

$ARDX

BEARISH2026-08-06

Price around the call

↓ 2026-08-06

By horizon✓ hit-4.8%

…

✗ +1.1%

21d

✓ -4.8%

Original post

BioPharm_the_Magnificent · 2026-08-06

$ARDX ER sucked. No way around it. However… They’re pulling the $750M XPHOZAH peak sales target because reimbursement is still stuck in the dialysis bundle. No TDAPA, slower adoption, guidance slashed. With the new CMS rule extending applications through Jan 1, 2028 and the 3-year window open until Oct 2026, Ardelyx could file for TDAPA at any time. (I think imminent) The reimbursement math may finally be shifting. I have a fraction of my original 200k shares and will be adding after my self-imposed 3 day rule.

View on X ↗